![1]()
News
FDA approves drug combo to treat highly resistant TB
August 14, 2019
The combination of pretomanid tablets with bedaquiline and linezolid primarily was approved for a limited population infected with drug resistant TB.
![1]()
News
Study: Cardiac biomarkers predicted CV events in CAP
August 13, 2019
The results suggest a change in usual practice is needed to reduce cardiovascular community-acquired pneumonia complications, according to a study author.
![1]()
News
Procalcitonin advocated to help rule out bacterial infections
August 13, 2019
SEATTLE – Use of procalcitonin may help decrease lumbar punctures and antibiotic exposure.
![1]()
News
Sepsis survivors’ persistent immunosuppression raises mortality risk
August 7, 2019
Individuals with persistent biomarkers of inflammation and immunosuppression had a higher risk of readmission and death because of cardiovascular disease.
![1]()
News
Dispatch from HM19: COPD updates
August 2, 2019
Every COPD exacerbation is associated with economic, social, and mortality burdens.
![1]()
News
Enteral feeding is safe during bronchiolitis HFNC
August 2, 2019
SEATTLE – Parents feel better when they know their children are “getting food in their belly.”
![1]()
News
Short-course azithromycin no benefit in pediatric asthma admissions
July 31, 2019
SEATTLE – Clinicians should consider these data before prescribing azithromycin to children hospitalized with asthma.
News
New analysis challenges fluid resuscitation guidelines for patients in shock
July 17, 2019
For children in shock, fluid resuscitation has counterproductive effects on respiratory and neurologic function.
![1]()
News
Patients with COPD at heightened risk for community-acquired pneumonia requiring hospitalization
July 11, 2019
COPD patients were about 18 times more likely to develop community-acquired pneumonia requiring hospitalization.
News
C-reactive protein testing reduced antibiotic prescribing in patients with COPD exacerbation
July 10, 2019
Fewer prescriptions, less reported antibiotic use, with no evidence of harm or reduced quality of life, according to PACE trial investigators.
